International Journal of Molecular Medicine · 2016 · 42 citations · 34 references
Life SciencesBiochemistryPharmacologyHepatic PharmacotherapyMetabolic RegulationMetabolismInsulin ResistanceLipid MetabolismLiver DiseaseMetabolic Liver DiseaseMetabolic SyndromeTriglyceride MetabolismCyclooxygenase PathwaysCyclooxygenase-2 PathwayHepatic Insulin ResistanceHepatic Triglyceride MetabolismMetabolic Enzyme InhibitionPeroxisome Proliferator-activated Receptor Gamma RegulationPeroxisome Proliferator-activated ReceptorsSelective Cyclooxygenase-2 Inhibitors
Cyclooxygenase (COX)-2 selective inhibitors suppress non-alcoholic fatty liver disease (NAFLD); however, the precise mechanism of action remains unknown. The aim of this study was to examine how the COX-2 selective inhibitor nimesulide suppresses NAFLD in a murine model of high-fat diet (HFD)‑induced obesity. Mice were fed either a normal chow diet (NC), an HFD, or HFD plus nimesulide (HFD-nime) for 12 weeks. Body weight, hepatic COX-2 mRNA expression and triglyceride accumulation were significantly increased in the HFD group. Triglyceride accumulation was suppressed in the HFD-nime group. The mRNA expression of hepatic peroxisome proliferator-activated receptor γ (PPARγ) and the natural PPARγ agonist 15-deoxy-Δ12,14-prostaglandin J2 (15d‑PGJ2) were significantly increased in the HFD group and significantly suppressed in the HFD-nime group. Glucose metabolism was impaired in the HFD group compared with the NC group, and it was significantly improved in the HFD-nime group. In addition, the plasma insulin levels in the HFD group were increased compared with those in the NC group, and were decreased in the HFD-nime group. These results indicate that HFD-induced NAFLD is mediated by the increased hepatic expression of COX-2. We suggest that the production of 15d-PGJ2, which is mediated by COX-2, induces NAFLD and hepatic insulin resistance by activating PPARγ. Furthermore, the mRNA expression of tissue inhibitor of metalloproteinases-1 (TIMP‑1), procollagen-1 and monocyte chemoattractant protein-1 (MCP-1), as well as the number of F4/80-positive hepatic (Kupffer) cells, were significantly increased in the HFD group compared with the NC group, and they were reduced by nimesulide. In conclusion, COX-2 may emerge as a molecular target for preventing the development of NAFLD and insulin resistance in diet-related obesity.
34
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Darren A.E. Cross, Dario R. Alessi, Philip Cohen et al. · Nature · 1995 · 5.2K citations
Cyclooxygenase in biology and disease
Raymond N. DuBois, Steven B. Abramson, Leslie J. Crofford et al. · The FASEB Journal · 1998 · 2.5K citations
C/EBPα induces adipogenesis through PPARγ: a unified pathway
Evan D. Rosen, Chung-Hsin Hsu, Xinzhong Wang et al. · Genes & Development · 2002 · 1.5K citations · Full text
Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Pere Puigserver, James Rhee, Jerry Donovan et al. · Nature · 2003 · 1.5K citations
Mechanism of Hepatic Insulin Resistance in Non-alcoholic Fatty Liver Disease
Varman T. Samuel, Zhen Xiang Liu, Xianqin Qu et al. · Journal of Biological Chemistry · 2004 · 1.3K citations · Full text